Bulatoc, Baby Girl .

HRN: 26-72-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2025
AMPICILLIN 500MG (VIAL)
02/17/2025
02/23/2025
IVT
85mg
Q6
Sepsis
Waiting Final Action 
02/17/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/17/2025
02/23/2025
IVT
25mg
Q24
Sepsis
Waiting Final Action 
02/17/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/17/2025
02/23/2025
IVT
26mg
Now
Sepsis
Waiting Final Action 
02/17/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/17/2025
02/23/2025
IVT
13mg
Q8
Sepsis
Waiting Final Action 
02/22/2025
CEFOTAXIME 500MG (VIAL)
02/22/2025
03/01/2025
IV
50 Mg
Q 8 Hours
Sepsis
Waiting Final Action 
02/22/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
02/22/2025
03/01/2025
IV
8 Mg
Q 24
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: